Magdalena Biosciences, Inc.
- | Biotech or pharma, therapeutic R&D
Jaguar Health (NASDAQ: JAGX) and Filament Health joint venture focused on plant-based Rx medicines for mental health, specifically neuropsychiatric FDA approved drugs. Project initiation to entry into clinical POC study in paradigm shift for drug development in 12-24 months. Improved chance of efficacy based on centuries of medicinal use. Multiple drug candidates ready to enter clinic in 2025/2026 for POC studies.
Address
DoverDelaware
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}